Tartaric Acid Synthetic Derivatives for Multi-Drug Resistant Phytopathogen Pseudomonas and Xanthomonas Combating
AbstractThe resistance to antimicrobial preparations, according the WHO reports of recent years, is becoming the one of the most actual healthcare problems of this century. Nevertheless, the key role of antibiotics diversity increase, as well as the increase of their application scopes, the initial origin of antimicrobial resistance problem is the versatility of adaptation mechanisms potential of all microorganisms, including intraspecific gene horizontal transfer and quorum sensing. Thus, the actuality of search of new, ecologically safe and harmless for human health antimicrobial agents, among the natural and semisynthetic compounds, is being significantly increased. One of the prospective directions in these research is the derivatization of aldaric acids, isolated from plants different species, as the native antibacterial active substances, such as like: citric, acetic, tartaric, lactic. In current research, 7 new derivatives of natural tartaric acid (TA): cyclohexylimide, benzylimide, phenylimide, benzyl mono amino salt, cyclohexyl mono amino salt, phenyl amino salt and mono ethanol amino salt of TA were tested on different strains from 6 subtypes of 3 species of phytopathogenic multi-drug resistant Xanthomonas and Pseudomonas. During the research it was detected the significant antimicrobial effect of studied compounds against the range of phytopathogens which are resistant to antibiotics from different classes and generations (ciprofloxacin, chloramphenicol, ceftriaxone, azithromycin, etc.). It was detected the higher efficiency of cyclohexyl- derivatives in comparison with mono ethanol-, phenyl- and benzyl- derivatives.
. A.T. Adesoji. Ogunjobi A.A., Olatoye I.O. “Molecular characterization of selected multidrug resistant Pseudomonas from water distribution systems in southwestern Nigeria”, Ann Clin Microbiol Antimicrob., 14, pp. 39, 2015.
. N.G.E. Chakhtoura. Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward “molecularly targeted” therapy, Expert Rev Anti Infect Ther., 16(2), pp. 89–110, 2018.
. R.-D. Jeong, E.-H. Chu, G.W. Lee, J.M. Park, H.-J. Park. "Effect of gamma irradiation on Pseudomonas syringae pv. tomato DC3000 – short communication", Plant Protection Science. 52 (2), pp. 107–112, 2016.
. M.P. Castañeda-Ojeda, A. Moreno-Pérez, C. Ramos, E. López-Solanilla. Suppression of Plant Immune Responses by the P. savastanoi pv. savastanoi NCPPB 3335 Type III Effector Tyr Phosphatases HopAO1 and HopAO2, Front. Plant Sci., 8(680), 1-15, 2017.
. J.M. Young, JP. Wilkie, DS. Park, DR. Watson. "New Zealand strains of plant pathogenic bacteria classified by multi-locus sequence analysis; proposal of X. dyei sp. nov". Plant Pathol., 59 (2): 270–281, 2010.
. N. Ah-You, L. Gagnevin, PA. Grimont, S. Brisse, X. Nesme, F. Chiroleu, et al. "Polyphasic characterization of xanthomonads pathogenic to members of the Anacardiaceae and their relatedness to species of Xanthomonas". Int. J. of Syst. & Evol. Microbiol. 59 (Pt 2): 306-18, 2009.
. J.L. Rademaker, FJ. Louws, MH. Schultz, U. Rossbach, L. Vauterin, J. Swings, et al. "A comprehensive species to strain taxonomic framework for Xanthomonas". Phytopathology. 95 (9): 1098–111. Sep. 2005.
. Xu Ying, Luo Qing-quan, Zh. Ming-Guo. Identification and Characterization of Integron-Mediated Antibiotic Resistance in the Phytopathogen X. oryzae pv. oryzae, PLoS One.; 8(2): e55962, 2013.
. G.B. Martin. "Suppression and Activation of the Plant Immune System by P. syringae Effectors AvrPto and AvrPtoB". Effectors in Plant–Microbe Interactions. pp. 123–154, 2011.
. G.G. De Araujo, F. Rodrigues, F.L.T. Gonçalves, D. Galante. ''Survival and ice nucleation activity of P. syringae strains exposed to simulated high-altitude atmospheric conditions'', Scientific Reports, vol. 9:7768, pp. 1-11, 2019.
. G.W. Sundin, N. Wang. Antibiotic Resistance in Plant-Pathogenic Bacteria, Annu Rev Phytopathol, vol. 25;56, pp. 161-180, 2018.
. C. Cholet, S. Claverol, O. Claisse, A. Rabot, A. Osowsky, V. Dumot, G. Ferrari, L. Gény. “Tartaric acid pathways in Vitis vinifera L. (cv. Ugni blanc): a comparative study of two vintages with contrasted climatic conditions”, BMC Plant Biol. vol. 16 pp. 144, 2016.
. WHO: “Ten Threats to global health in 2019” (https://www.who.int/emergencies/ten-threats-to-global-health-in-2019), 2019.
. SQ. An, N. Potnis, M. Dow, FJ. Vorhölter, YQ. He, A. Becker, et al. "Mechanistic insights into host adaptation, virulence and epidemiology of the phytopathogen Xanthomonas". FEMS Microbiology Reviews: fuz 024, Oct. 2019.
. S. DeBolt, D.R. Cook, C.M. Ford. ”L-Tartaric acid synthesis from vitamin C in higher plants”, Proc Natl Acad Sci U S A., vol.103(14) pp. 5608–5613, 2006.
. C. Nunes, A. Duarte, D. Caixeirinho. “Organic Acids Concentration in Citrus Juice from Conventional versus Organic Farming”, Acta Hort. (ISHS), 933, pp. 601-606, 2012.
. R.G. Maroun, H.N. Rajha, E. Vorobiev and N. Louka. 7 - Emerging Technologies for the Recovery of Valuable Compounds From Grape Processing By-Products, Handbook of Grape Processing By-Products Sustainable Solutions, pp. 155-181, 2017.
. M. Malik, Sh. W. Khan, M. Arfan, J. H. Zaidi, A. Bano, F. Ullah. “Biological Evaluation of Chiral Amides Synthesized from Diacetyl-L-tartaric Acid and Aromatic Amines”, Asian Journal of Chemistry, 25(2) pp. 745-748, 2013.
. Sh.W. Khan, S. Naz, J.H. Zaidi, N. Ambreen, K.M. Khan, Sh. Perveen, GH.A. Miana. “Synthesis and Antimicrobial Activity of Chiral Imides from Diacetyl-L-Tartaric Acid Anhydride and Different Amino Acids”, Journal of Pharmacy Research, 5(1), pp. 646-650, 2012.
. A.R. Mikaelyan, N.L. Asatryan, S.A. Bagdasaryan, B.G. Babayan. “Antimicrobial Activity of Newly Synthesized Derivatives of Tartaric Acid Against the Multidrug Resistant Soil Strains of Pseudomonas and Stenotrophomonas”, ARICBE/ARICPAS-2019, Cambridge Univ., Abstract Book, Cambridge, UK, 1-2. 2019.
. B.G. Babayan, A.R. Mikaelyan, S.M. Shahinyan. S.A. Bagdasaryan. “Tartaric Acid New Derivatives Effect Against the Soil Pseudomonas and Stenotrophomonas as A Model for Research of Cave Infection Bacteria Antibiotic Resistance Combating, the book of Abstracts of "Int. Conf. ''Caves as Natural & Cultural Monuments'', Yerevan, RA, pp. 22 -23, 2019.
. N.A. Dashchyan, N.L. Asatryan, G.F. Galstyan, A.R. Mikaelyan. “Obtaining Bioactive Additives of Cyclic Structure on the Basis of Optically Active Tartaric Acid”, Bulletin of NPUA, Coll. of Sci. papers, 2, pp. 682-683, 2014
. B. Babayan. “The Plasmid Differences In Multi-Drug Resistant Opportunistic Pathogenic Soil Strains of Pseudomonas and Stenotrophomonas,” EJMN, 3(1), pp. 23-28, 2019.
. M.O. Birger. “Handbook of microbial.l & virology. methods of research”, pp.303-310, 354. 1982
. K.D. Chaudhary, A. Khulan, J. Kim."Development of a novel cultivation technique for uncultured soil bacteria", Scientific Reports, vol.9 (6666), pp. 10 11, 2019.
. S.D. Ellis, MJ. Boehm, D. Coplin. "Bacterial Diseases of Plants". Ohio St. Univ. Fact Sheet, 2008.
Copyright (c) 2020 International Journal of Sciences: Basic and Applied Research (IJSBAR)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who submit papers with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- By submitting the processing fee, it is understood that the author has agreed to our terms and conditions which may change from time to time without any notice.
- It should be clear for authors that the Editor In Chief is responsible for the final decision about the submitted papers; have the right to accept\reject any paper. The Editor In Chief will choose any option from the following to review the submitted papers:A. send the paper to two reviewers, if the results were negative by one reviewer and positive by the other one; then the editor may send the paper for third reviewer or he take immediately the final decision by accepting\rejecting the paper. The Editor In Chief will ask the selected reviewers to present the results within 7 working days, if they were unable to complete the review within the agreed period then the editor have the right to resend the papers for new reviewers using the same procedure. If the Editor In Chief was not able to find suitable reviewers for certain papers then he have the right to accept\reject the paper.B. sends the paper to a selected editorial board member(s). C. the Editor In Chief himself evaluates the paper.
- Author will take the responsibility what so ever if any copyright infringement or any other violation of any law is done by publishing the research work by the author
- Before publishing, author must check whether this journal is accepted by his employer, or any authority he intends to submit his research work. we will not be responsible in this matter.
- If at any time, due to any legal reason, if the journal stops accepting manuscripts or could not publish already accepted manuscripts, we will have the right to cancel all or any one of the manuscripts without any compensation or returning back any kind of processing cost.
- The cost covered in the publication fees is only for online publication of a single manuscript.